Aaron Weitzman is a Health Tech Deals Reporter at RamaOnHealthcare. He covers a range of topics within the healthcare sector, including startups, venture capital, and the intersection of technology and medicine, with a focus on AI and biotech innovations. Aaron's insights and reporting have been featured in notable publications such as RamaOnHealthcare and Axios.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Aaron Weitzman's coverage is primarily focused on the intersection of big tech and healthcare, with a specific emphasis on health technology and mergers and acquisitions within the industry. His reporting also includes private sector announcements, government announcements, press releases, and data citations.
Given this focus, individuals or companies involved in health technology innovations or M&A activities within the healthcare sector may find success reaching out to Aaron with relevant news such as product launches, funding rounds, partnerships, regulatory updates impacting the industry etc. Additionally providing access to exclusive data insights can be an effective approach to pitch ideas for potential coverage.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Morgan Health,
Prospect Medical Holdings'
By: Erin Brodwin, Aaron Weitzman, Claire Rychlewski
Despite antitrust scrutiny over UnitedHealth's dominance in the provider market, its Optum unit continues to acquire specialty providers.
This year could finally see the deal backlog in health care ease, particularly among PE-backed companies.
Anyone hoping for a resurgence of 2021-era optimism may be disappointed as investors batten down the hatches.
Safety and stability were the unspoken themes
After several years in the doldrums,
The Trump administration inherited
The NYC company relies on AI and automation to recruit patients and facilitate new trial designs.
UnitedHealth Group and Amedisys will likely
(833) 317-6278 
